Systematic analysis of adverse reaction signals induced by leflunomide, upadacitinib, and baricitinib in the treatment of rheumatoid arthritis: a FAERS database analysis

• by Jizheng Dang, Li Shu

• July 21, 2026

Beyond the trial: a single-center retrospective review of real-world lupus nephritis management and outcomes

• by Dylan Clapp, Mugdha Kulkarni, Anthony C. Leonard, Manish Anand

• July 21, 2026

Efficacy and safety of obinutuzumab in refractory membranous nephropathy: a single-arm meta-analysis

• by Pengli Cong, Jiayang Wang, Xuanyi Du

• July 21, 2026

Serostatus May Modify RA Activity–CV Link

Combined rheumatoid factor and anticitrullinated protein antibody status appeared to modify the association between baseline rheumatoid arthritis disease activity and subsequent cardiovascular events in an international observational cohort.

• by Andrea Surnit

• July 15, 2026

• 4 min